Nabil Lally: Accelerating the Journey from Molecule to Cure
Nabil Lally, Senior Director of Business Development at Quotient Sciences, is a driving force in the evolution of drug development. With over a decade of experience in clinical pharmacology and pharmaceutical development, Nabil blends deep scientific knowledge with strategic expertise to help pharmaceutical and biotech companies bring life-changing therapies to patients—faster and more efficiently.
A passionate advocate of Translation... moreNabil Lally: Accelerating the Journey from Molecule to Cure
Nabil Lally, Senior Director of Business Development at Quotient Sciences, is a driving force in the evolution of drug development. With over a decade of experience in clinical pharmacology and pharmaceutical development, Nabil blends deep scientific knowledge with strategic expertise to help pharmaceutical and biotech companies bring life-changing therapies to patients—faster and more efficiently.
A passionate advocate of Translational Pharmaceutics®, Nabil has played a pivotal role in expanding this integrated platform that combines formulation development, GMP manufacturing, and clinical testing into a single, adaptive process. The impact is tangible: over 300 programs supported globally, significant reductions in R&D costs, and up to 12 months saved on development timelines. For companies navigating the complex early stages of drug development, Nabil offers a streamlined path that doesn’t compromise on quality or flexibility.
Nabil’s insights are frequently sought at high-profile industry events including BIO International, DCAT Week, and ASCPT, where he speaks on critical topics like adaptive clinical trial designs, real-time clinical data integration, and the role of AI in modern drug development. His consultative and collaborative approach empowers partners to make smarter decisions—reducing risk while increasing speed and certainty.
But for Nabil, the mission goes beyond business metrics. It’s about impact. It’s about making sure patients don’t have to wait years for a treatment that could transform or even save their lives. His work reflects a clear sense of purpose: to bridge science and innovation with real-world urgency.
Nabil Lally continues to shape the future of drug development—bringing cutting-edge therapies to market with a bold, patient-first mindset. In a world where every second counts, he’s helping the industry move from molecule to cure, faster than ever before.
